Technical Analysis for FULC - Fulcrum Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 10.96 -5.35% -0.62
FULC closed down 5.35 percent on Thursday, December 5, 2019, on 39 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Down
See historical FULC trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -5.35%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.35%
Wide Bands Range Expansion -5.35%
1,2,3 Pullback Bullish Bullish Swing Setup -10.82%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -10.82%
Wide Bands Range Expansion -10.82%

Older signals for FULC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that are developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-HbF, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and b-thalassemia. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Medicine Biopharmaceutical Medical Specialties Diseases Muscular Dystrophy Infancy Disorder Sickle Cell Disease Facioscapulohumeral Muscular Dystrophy Hemoglobins

Is FULC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Indicators
Indicator Value
52 Week High 15.94
52 Week Low 4.37
Average Volume 64,389
200-Day Moving Average 0.00
50-Day Moving Average 7.79
20-Day Moving Average 10.60
10-Day Moving Average 12.86
Average True Range 1.16
ADX 39.39
+DI 27.70
-DI 21.61
Chandelier Exit (Long, 3 ATRs ) 11.76
Chandelier Exit (Short, 3 ATRs ) 9.38
Upper Bollinger Band 15.88
Lower Bollinger Band 5.31
Percent B (%b) 0.53
BandWidth 99.83
MACD Line 1.37
MACD Signal Line 1.49
MACD Histogram -0.1205
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.12
Resistance 3 (R3) 12.23 11.96 11.92
Resistance 2 (R2) 11.96 11.67 11.90 11.86
Resistance 1 (R1) 11.46 11.48 11.33 11.35 11.79
Pivot Point 11.19 11.19 11.12 11.13 11.19
Support 1 (S1) 10.69 10.90 10.56 10.58 10.13
Support 2 (S2) 10.42 10.71 10.36 10.06
Support 3 (S3) 9.92 10.42 10.00
Support 4 (S4) 9.81